⚛️ Quantum Navigator

Exploring The Quantum Industry

Lansdowne Partners

Hedge Fund / VC

Overview

Lansdowne Partners

Investment management firm with venture investments in quantum technology

Investor Information

  • Type: Hedge Fund / VC
  • Founded: 1998
  • Headquarters: London, UK
  • Fund Size: $15B+ AUM
  • Investment Stage: Series A to Series B ($20M-$50M)
  • Website: https://www.lansdownepartners.com

Investment Focus

Technology, Healthcare, Quantum

Key People

Stuart Roden (Co-founder & CEO)

Notable Portfolio Companies

  • Genomics
  • Oxford Ionics

← Back to All Investors

Key Information

🏢

Type

Hedge Fund / VC

📅

Founded

1998

📍

Headquarters

London, UK

💰

Fund Size

$15B+ AUM

📊

Investment Stage

Series A to Series B ($20M-$50M)

🎯

Focus Areas

Technology, Healthcare, Quantum

Key People

Stuart Roden (Co-founder & CEO)

Related Resources

⚠️ Important Disclaimer

Information for Educational Purposes Only: All information about Lansdowne Partners is provided for informational and educational purposes only. This is not investment, financial, or professional advice.

No Investment Recommendations: Nothing on this page constitutes a recommendation to invest in any fund or company. Always conduct your own research and consult with qualified financial advisors before making investment decisions.

Accuracy: While we strive for accuracy, information may be incomplete or outdated. Please verify all details directly with Lansdowne Partners or through their official channels.

Third-Party Information: Portfolio company information and investment details are obtained from public sources and have not been verified for accuracy.